Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 41.31 and traded as high as GBX 42. Faron Pharmaceuticals Oy shares last traded at GBX 40.11, with a volume of 8,219 shares.
Faron Pharmaceuticals Oy Stock Down 1.0%
The company has a debt-to-equity ratio of -133.35, a current ratio of 0.84 and a quick ratio of 1.09. The firm has a market cap of £81.38 million, a PE ratio of -1.82 and a beta of 1.12. The business’s 50 day moving average price is GBX 41.31 and its 200 day moving average price is GBX 49.81.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Further Reading
- Five stocks we like better than Faron Pharmaceuticals Oy
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
